Table of Contents Table of Contents
Previous Page  1172-1173 / 2063 Next Page
Information
Show Menu
Previous Page 1172-1173 / 2063 Next Page
Page Background

ARCON for cT2-4 larynx carcinoma

49

78% AR

79% ARCON

86% AR

93% ARCON

Janssens et al., J Clin Oncol 2012

345 patients